1Carella C, Mazziotti G, Sorvillo F, et al. Serum thyrotropin receptor antibodies concentrations in patients with Graves' disease before, at the end of methimazole treatment, and after drug withdrawal: evidence that the activity of thyrotropin receptor antibody and/or thyroid response modify during the observation period[J]. Thyroid, 2006, 16(3):295.
4Cappelli C, Gandossi E, Castellano M, et al. Prognostic value of thyrotropin receptor antibodies (TRAb) in Graves' Disease: a 120 month prospective study [J]. Endocr J, 2007,54 (5):713.
